121
Views
6
CrossRef citations to date
0
Altmetric
Research Articles

Mitotane liposomes for potential treatment of adrenal cortical carcinoma: ex vivo intestinal permeation and in vivo bioavailability

, , , , , , ORCID Icon & show all
Pages 949-961 | Received 14 Jun 2019, Accepted 27 Apr 2020, Published online: 19 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Rebecca V. Steenaard, Madeleine H.T. Ettaieb, Thomas M.A. Kerkhofs & Harm R. Haak. (2021) How close are we to personalized mitotane dosing in the treatment of adrenocortical carcinoma? State of the art and future perspectives. Expert Opinion on Drug Metabolism & Toxicology 17:6, pages 677-683.
Read now

Articles from other publishers (4)

Shuwen Zhou, Xinmeng Zheng, Ke Yi, Xuancheng Du, Cheng Wang, Pengfei Cui, Pengju Jiang, Xinye Ni, Lin Qiu & Jianhao Wang. (2022) Temperature-Ion-pH Triple Responsive Gellan Gum as In Situ Hydrogel for Long-Acting Cancer Treatment. Gels 8:8, pages 508.
Crossref
Payal Kesharwani, Kajal Kumari, Ritika Gururani, Smita Jain & Swapnil Sharma. (2022) Approaches to Address PK-PD Challenges of Conventional Liposome Formulation with Special Reference to Cancer, Alzheimer's, Diabetes, and Glaucoma: An Update on Modified Liposomal Drug Delivery System. Current Drug Metabolism 23:9, pages 678-692.
Crossref
Malik Salman Haider, Taufiq Ahmad, Jürgen Groll, Oliver Scherf-Clavel, Matthias Kroiss & Robert Luxenhofer. (2021) The Challenging Pharmacokinetics of Mitotane: An Old Drug in Need of New Packaging. European Journal of Drug Metabolism and Pharmacokinetics 46:5, pages 575-593.
Crossref
Carolin Langer & Regine Süss. (2021) HPLC-DAD-CAD-based approach for the simultaneous analysis of hydrophobic drugs and lipid compounds in liposomes and for cyclodextrin/drug inclusion complexes. Journal of Pharmaceutical and Biomedical Analysis 201, pages 114120.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.